VC/I  Nest.Bio Ventures

https://nest.bio





     Office Locations:

43 Charles Street, 2nd Floor
Boston, MA 02114

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Nest.Bio Ventures is a venture creation and venture capital firm leveraging technological advancements to create next-generation therapeutics. By combining deep scientific expertise, a data-driven approach, and broad, international academic and industrial networks, we help transform scientific breakthroughs into revolutionary companies. Nest.Bio Labs is a shared facility designed to house and support visionary life sciences companies. Nest.Bio Labs offers a dynamic, supportive, and collaborative atmosphere-including laboratory and business training, an expert speaker series, and networking opportunities with a broad array of academics, scientists, pharmaceutical companies, and venture funds.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    James W. Weis Partner
    Lorena Dai Analyst

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      02/27/2018


      Senti Biosciences


      CA


      $53,000,000


      


      01/31/2018


      Engine Biosciences


      CA


      $10,000,000


      Seed


      11/30/2017


      resTORbio


      MA


      $40,000,000


      Series B


     

    Portfolio companies include:


      Engine Biosciences
        web link


      HiFiBiO
        web link


      Platelet Biogenesis
        web link


      resTORbio
        web link


      Senti Biosciences
        web link


     

    Recent News: